Stock data

合世 (1781)

合世 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$27.52M, up 17.2% from a year earlier. EPS over the last four quarters totals -NT$1.07.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 合世 in Insightr